NFE2L2 and neuroblastoma: One such product is 12,13-epoxy-9-keto-10(trans)-octadecenoic acid (EKODE), which activates ARE in primary cells and IMR-32 human neuroblastoma cells, mediated by the transcription factor Nrf2 [146].